Icon, a clinical-trial outsourcing company based in Dublin, has acquired PriceSpective, a Philadelphia-based analytics and consulting company.
Philly analytics provider sold to Irish company
Icon, which markets its services to pharmaceutical, biotechnology and medical device companies, said in a news release that the deal would boost its value-based pricing and market access services. "Payers are increasingly demanding evidence not only of product efficacy, but also value for money, which has led to an upsurge in client demand for research that links efficacy, value and price," Icon CEO Ciaran Murray said in the release.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.